| Up
2005P-0104:
DETERMINE WHETHER PEPTAVLON (PENTAGASTRIN) WAS VOLUNTARILY WITHDRAWN
FROM SALE FOR REASONS OTHER THAN SAFETY OR EFFECTIVENESS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 03/15/2005
|
| 03/15/2005
|
| Private Industry
|
| Arnall Golden Gregory
LLP
|
|
|
|
|
|
|
| pdf,
Attachments: A,
B
|
|
|
|
|
| Signature:
|
| Alan G. Minsk
|
|
|
|
|
| ACK1
|
| 03/15/2005
|
| 03/15/2005
|
| Private Industry
|
| HFA-305 to Arnall
Golden Gregory LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
| |
Top
| Up
Page last updated
May 17, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
